Navigation Links
Lupus Research Institute strategy delivers $30 million in national funding
Date:11/19/2007

through discoveries in such diverse fields as genetics, molecular science, cardiovascular disease, kidney disease, cognitive science, biomarkers, and pathways to autoimmune attack. Discoveries include:

  • 20 potential lupus biomarkers early predictors of disease and treatment effectiveness; six are now in clinical investigation and human testing.
  • Genes that increase susceptibility to lupus
  • Pathways that enable misguided antibodies to attack
  • Molecules that determine control of the immune system
  • Targets for new treatments
  • Insights on how lupus damages organs the heart, kidneys, brain, skin

Im grateful to the LRI for being brave enough to fund unusual work at an early stage of development, said Philip Cohen, MD, of the University of Pennsylvania, who received an LRI research grant in 2001 and is continuing his investigations. This initial funding was responsible for getting what is now a very large project off the ground.


'/>"/>

Contact: Liane Stegmaier
lstegmaier@lupusny.org
212-812-9881
Lupus Research Institute
Source:Eurekalert

Page: 1 2

Related biology news :

1. Study identifies genetic risk factor for rheumatoid arthritis, lupus
2. Research shows skeleton to be endocrine organ
3. Newly created cancer stem cells could aid breast cancer research
4. Dominant cholesterol-metabolism ideas challenged by new research
5. Researchers identify proteins involved in new neurodegenerative syndrome
6. Texas researchers and educators head for Antarctica
7. MGH researchers describe new way to identify, evolve novel enzymes
8. University of Pennsylvania researchers develop formula to gauge risk of disease clusters
9. University of Oregon researcher finds that on waters surface, nitric acid is not so tough
10. U of MN researchers discover noninvasive diagnostic tool for brain diseases
11. U of Minnesota researchers discover noninvasive diagnostic tool for brain diseases
Post Your Comments:
*Name:
*Comment:
*Email: